Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
102.73
+0.30 (0.29%)
Dec 2, 2025, 4:00 PM EST - Market closed
Revvity Employees
Revvity had 11,000 employees as of December 29, 2024. The number of employees decreased by 500 or -4.35% compared to the previous year.
Employees
11,000
Change (1Y)
-500
Growth (1Y)
-4.35%
Revenue / Employee
$255,761
Profits / Employee
$21,589
Market Cap
11.65B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 11,000 | -500 | -4.35% |
| Dec 31, 2023 | 11,500 | -5,200 | -31.14% |
| Dec 31, 2022 | 16,700 | 0 | - |
| Dec 31, 2021 | 16,700 | 2,700 | 19.29% |
| Dec 31, 2020 | 14,000 | 1,000 | 7.69% |
| Dec 31, 2019 | 13,000 | 500 | 4.00% |
| Dec 31, 2018 | 12,500 | 1,500 | 13.64% |
| Dec 31, 2017 | 11,000 | 3,000 | 37.50% |
| Dec 31, 2016 | 8,000 | 0 | - |
| Dec 31, 2015 | 8,000 | 300 | 3.90% |
| Dec 31, 2014 | 7,700 | 100 | 1.32% |
| Dec 31, 2013 | 7,600 | 100 | 1.33% |
| Dec 31, 2012 | 7,500 | 300 | 4.17% |
| Dec 31, 2011 | 7,200 | 1,000 | 16.13% |
| Dec 31, 2010 | 6,200 | -2,000 | -24.39% |
| Dec 31, 2009 | 8,200 | 300 | 3.80% |
| Dec 31, 2008 | 7,900 | -800 | -9.20% |
| Dec 31, 2007 | 8,700 | 200 | 2.35% |
| Dec 31, 2006 | 8,500 | 500 | 6.25% |
| Dec 31, 2005 | 8,000 | -2,000 | -20.00% |
| Dec 31, 2004 | 10,000 | 0 | - |
| Dec 31, 2003 | 10,000 | -700 | -6.54% |
| Dec 31, 2002 | 10,700 | -100 | -0.93% |
| Dec 31, 2001 | 10,800 | -1,700 | -13.60% |
| Dec 31, 2000 | 12,500 | 500 | 4.17% |
| Dec 31, 1999 | 12,000 | -1,000 | -7.69% |
| Dec 31, 1998 | 13,000 | -1,000 | -7.14% |
| Dec 31, 1997 | 14,000 | -1,000 | -6.67% |
| Dec 31, 1996 | 15,000 | 0 | - |
| Dec 31, 1995 | 15,000 | -10,000 | -40.00% |
| Dec 31, 1994 | 25,000 | -7,000 | -21.88% |
| Dec 31, 1993 | 32,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RVTY News
- 11 hours ago - Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 14 days ago - Revvity, Inc. (RVTY) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 22 days ago - Revvity, Inc. (RVTY) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 22 days ago - Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay Accuracy - Business Wire
- 22 days ago - Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities - Business Wire
- 5 weeks ago - Revvity Analysts Increase Their Forecasts After Q3 Earnings - Benzinga
- 5 weeks ago - Revvity to Present at Upcoming Investor Conferences - Business Wire
- 5 weeks ago - Revvity: Software Momentum And Screening Offset China Weakness - Seeking Alpha